Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-07

Clinical Trial Update: Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® Inhaler [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated handling errors when adults currently using the SERETIDE DISKUS inhaler used the SERETIDE MDI, to assess differences in usage techniqu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SERETIDE MDI (salmeterol/fluticasone propionate)
  • Seretide Diskus (salmeterol/fluticasone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2016-07-07